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Abstract
Background: Mechanisms that affect recovery from fetal and neonatal hypoxic-ischemic (H-I) brain injury
have not been fully elucidated. The incidence of intrapartum asphyxia is approximately 2.5%, but the
occurrence of adverse clinical outcome is much lower. One of the factors which may account for this
relatively good outcome is the process of neurogenesis, which has been described in adult animals. We
used a neonatal mouse model to assess new cells in the hippocampus after H-I injury.
Results: Neonatal mice underwent permanent unilateral carotid ligation on the seventh postnatal day
followed by exposure to 8% hypoxia for 75 minutes. The presence of new cells was determined by
bromodeoxyuridine (BrdU) incorporation into cells with sacrifice of the animals at intervals. Brain sections
were stained for BrdU in combination with neuronal, glial, endothelial and microglial stains.
We found a significant increase in BrdU-positive cells in the neonatal mouse hippocampus in the injured
area compared to the non-injured area, most prominent in the dentate gyrus (DG) (154.5 ± 59.6 v. 92.9
± 32.7 at 3 days after injury; 68.9 ± 23.4 v. 52.4 ± 17.1 at 35 days after injury, p < 0.0011). Among the cells
which showed differentiation, those which were stained as either microglial or endothelial cells showed a
peak increase at three days after the injury in the DG, injured versus non-injured side (30.5 ± 17.8 v. 2.7
± 2.6, p < 0.0002). As in the adult animal, neurogenesis was significantly increased in the DG with injury
(15.0 ± 4.6 v. 5.2 ± 1.6 at 35 days after injury, p < 0.0002), and this increase was subsequent to the
appearance of the other dividing cells. Numbers of new oligodendrocytes were significantly higher in the
DG on the non-injured side (7.0 ± 24.2 v. 0.1 ± 0.3, p < 0.0002), suggesting that oligodendrocyte synthesis
was reduced in the injured hippocampus.
Conclusion: These findings demonstrate that the neonatal animal responds to brain injury with
neurogenesis, much like the adult animal. In addition, H-I insult leads to more neurogenesis than
hypoxia alone. This process may play a role in the recovery of the neonatal animal from H-I insult,
and if so, enhancement of the process may improve recovery.
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Background
The incidence of intrapartum asphyxia was recently deter-
mined to be 2.5% in a large population of singleton preg-
nancies [1]. Even so, the occurrence of adverse
neurological outcome following delivery is actually much
lower. There are undoubtedly a number of reasons why
greater numbers of infants do not suffer lasting neurolog-
ical impairment, but one of the reasons may be the forma-
tion of new cells in the damaged tissue. Recent studies
have demonstrated the presence of multipotent neural
stem cells in the subventricular zone and the subgranular
zone of the hippocampus [2]. Hippocampal stem cells
from the adult brain have been demonstrated to prolifer-
ate and differentiate into neurons, astrocytes, and oli-
godendrocytes [3], as a response to multiple factors,
including hypoxic-ischemic (H-I) injury, or trauma [4,5].
New neuronal growth has been demonstrated in several
studies of adult H-I models, including in humans [6-10],
but this finding has received less attention in neonatal
animals. The pluripotent stem cells found in the neonatal
brain have not been characterized as completely as those
in the adult brain. As this process may be relevant to the
recovery of the neonatal brain from H-I injury, we sought
to determine whether new cells arose in the neonatal
brain following this type of injury. Bromodeoxyuridine
(BrdU) is a thymidine analog incorporated into the DNA
of dividing cells, rendering them detectable by immuno-
histochemical means [11]. We employed a neonatal
mouse H-I brain injury model with BrdU injection to
determine what types of BrdU-positive cells are present in
the hippocampus after an H-I event and to determine if
this response if different than that due to hypoxia alone.
Results
Figure 2 shows the area of damage produced in the
affected hippocampus. The majority of the BrdU positive/
NeuN positive cells were found in the granule cell layer on
the experimental side. The side of the hippocampus con-
tralateral to ligation, although also exposed to hypoxia,
did not demonstrate the same degree of injury, remaining
histologically normal in appearance. The finding that
common carotid artery occlusion or hypoxia alone does
not cause apparent brain damage has been previously
reported [12,13]. Thus, we compared the hypoxia alone
side of the brain to the hypoxic-ischemic side of the brain
in the statistical analyses.
Regional differences
The DG on the hypoxic-ischemic side of the brain exhib-
ited significantly higher numbers of BrdU-positive cells at
P10, P17, and P42 than either CA1 or CA3. BrdU/RCA-
positive cells were significantly higher at P10 in the DG.
The morphology and location of the BrdU/RCA-positive
cells suggested that they were endothelial or microglial
cells. BrdU/NeuN-positive cells were higher at P17 and
P42 in the DG (Table 1).
Hypoxia alone versus hypoxic-ischemic side differences
Table 2 shows the trends in the DG at the three sacrifice
times for hypoxia alone and hypoxic-ischemic sides of the
brain. BrdU-positive cells without co-labeling and BrdU/
RCA-positive cells occur first after the H-I injury (signifi-
cant increase at P10), followed by BrdU/NeuN-positive
cells (significant increase at P42). Colabeling of BrdU and
NeuN was confirmed by confocal microscopy (Figure 2).
For BrdU/CNPase-positive cells the only significant differ-
ence was seen in the DG at 10 days, where the hypoxia
alone side was significantly higher (7.0 ± 24.2 v. 0.1 ± 0.3,
p < 0.0002). No significant differences were seen in the
BrdU/GFAP-positive cells when the hypoxic-ischemic side
was compared with the hypoxia alone side. Both GFAP
positive and CNPase positive cells without BrdU staining
were seen in appropriate areas.
Table 1: Regional differences in injured side: Numbers of cells
Age at sacrifice: stain CA1 CA3 DG
P10: BrdU 120.6 ± 39.7 109.7 ± 37.4 154.5 ± 59.6*
P10: BrdU/RCA 19.8 ± 12.2 15.1 ± 6.1 30.5 ± 17.8**
P10: BrdU/NeuN 0 0 0.2 ± 0.6
P17: BrdU 61.4 ± 21.7 49.6 ± 17.1 98.7 ± 26.2*
P17: BrdU/RCA 12.5 ± 4.1 6.2 ± 4.5 8.6 ± 3.8
P17: BrdU/NeuN 0.4 ± 0.7 0.3 ± 0.6 11.6 ± 4.4**
P42: BrdU 31.7 ± 19.4 35.0 ± 21.6 68.9 ± 23.4*
P42: BrdU/RCA 5.7 ± 5.8 2.7 ± 2.0 6.3 ± 4.5
P42: BrdU/NeuN 0 0.3 ± 0.8 15.0 ± 4.6**
*Significantly greater than CA1 or CA3, p < 0.0011
**Significantly greater than CA1 or CA3, p < 0.0002BMC Neuroscience 2005, 6:15 http://www.biomedcentral.com/1471-2202/6/15
Page 3 of 9
(page number not for citation purposes)
Discussion
The hippocampus has been the focus of much research
involving H-I injury, both for its susceptibility to H-I
injury and its regenerative capacity due to the adult neural
stem cells found there. The bulk of this work has been
compiled using adult models of H-I injury. In the neona-
tal mouse, the degree of damage to the hippocampus from
this type of injury has been found to be variable, based on
multiple factors, including the strain of mouse used [16].
In addition, the timing of the insult has been demon-
strated to affect the severity of damage. The mouse hip-
pocampus is remarkably resistant to H-I injury at 2–3
Hippocampal injury following hypoxic-ischemic injury in a P17 mouse Figure 2
Hippocampal injury following hypoxic-ischemic injury in a P17 mouse. A – HI injury (small arrows), triple filter 100X; B – colo-
calization with NeuN and BrdU, triple filter, 400X; C – BrdU label alone, Cy3 filter, 400X; D – NeuN label alone, FITC filter, 
400X; and E – Hoechst counterstain, DAPI filter, 400X. B through E shows the same field. The large arrows show a neuron 
with BrdU and NeuN staining, demonstrating that the cell has recently divided. The circles show the three areas where the 
counting was performed.
Table 2: Injured versus non-injured dentate gyrus side differences: Numbers of cells
Stain: Side of brain P10 P17 P42
BrdU
Injured 154.5 ± 59.6* 98.7 ± 26.2 68.9 ± 23.4*
Non-injured 92.9 ± 32.7 86.7 ± 21.5 52.4 ± 17.1
BrdU/RCA
Injured 30.5 ± 17.8** 8.6 ± 3.8** 6.3 ± 4.5
Non-injured 2.7 ± 2.6 2.4 ± 2.4 1.1 ± 1.1
BrdU/NeuN
Injured 0.2 ± 0.6 11.6 ± 4.4 15.0 ± 4.6**
Non-injured 0.1 ± 0.3 6.6 ± 3.2 5.2 ± 1.6
*Significantly greater than control, p < 0.0011
**Significantly greater than control, p < 0.0002BMC Neuroscience 2005, 6:15 http://www.biomedcentral.com/1471-2202/6/15
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post-natal days but becomes progressively vulnerable, and
by age 13 post-natal days hippocampal damage exceeds
that of cortex [16]. Scheepens et al [17] found an increase
in proliferation of hippocampal cells following global
asphyxia in the newborn rat, much as we found in the
model we used, but these investigators did not assess mat-
uration of the proliferating cells into neurons and other
cell types. In one study neonatal hypoxia alone triggered
neurogenesis in a neonatal rat model [18]. The changes
they noted were mainly in the CA1 region, as opposed to
the DG, where we found the primary changes. Because the
hippocampus is vulnerable to H-I damage and has the
potential for neurogenesis, yet has not been extensively
examined in a neonatal model, the hippocampus was the
focus for this study.
We can summarize the regenerative process as follows: the
initial phase is characterized by comparatively large num-
bers of incompletely differentiated cells, primarily in the
DG (10 days of age or 3 days after injury), followed rap-
idly by the appearance of BrdU/RCA-positive cells, again
mainly in the DG, and then by BrdU/NeuN-positive cells
(putative neurons) developing only in the DG (at 42 days
of age). There were minimal numbers of BrdU/GFAP-pos-
itive cells observed at all points.
Ischemia has been shown to increase neurogenesis in sev-
eral adult animal models of brain ischemia. Following
global cerebral ischemia in adult gerbils, neurogenesis has
been shown to increase in the hippocampal SGZ, while
newly born neurons were demonstrated in the CA1
pyramidal cell layer [8]. In another study of adult gerbils,
after 10 minutes of bilateral carotid occlusion, newborn
cells with a neuronal phenotype were first seen 26 days
after injury [5]. In the adult rat, ischemia has been shown
to increase the incorporation of BrdU-positive cells co-
expressing neuronal markers in both the DG and the SVZ
[7]. Furthermore, this effect was more prominent on the
side of ischemic insult [7]. Similar studies in the adult rat
demonstrate that up to 60 percent of the new cells found
after this type of ischemic brain damage demonstrate neu-
ronal characteristics. In adult mice, after transient fore-
brain ischemia, BrdU-positive cells have been
demonstrated to significantly increase in the DG [4]. In
view of the fact that we observed the BrdU/NeuN-positive
cells to increase only in the DG, it seems probable that the
regenerative process in neonates is similar to that in adult
animals.
The data strongly suggested that the development of oli-
godendrocytes (BrdU/CNPase-positive cells) was
impaired in the DG on the hypoxic-ischemic side of the
brain, with significantly fewer of these cells observed in
the hypoxic-ischemic side as compared to the hypoxia
alone side at 10 days. This finding is in contradiction to
findings reported by Zaidi et al [19], who demonstrated
that neonatal H-I injury in rats led to increased numbers
of oligodendrocytes ipsilateral to H-I injury. There are sev-
eral possible explanations for this discrepancy. In our
study, oligodendrocytes were found to be decreased on
the side of the brain ipsilateral to carotid ligation at P10.
In the Zaidi study, they were found to be increased at P35.
It is possible that oligodendrocytes proliferate at the site
of damage after P10. It is also possible that the oli-
godendrocytes are at the site of damage at P10, but are not
mature enough to stain with CNPase. Lastly, the Zaidi
group evaluated the SVZ, while we reported dual staining
in the hippocampus. There could be regional differences
between the two.
White matter damage in neonates is thought to be in part
due to vulnerability of the immature oligodendrocyte to
H-I damage [20]. In several neonatal animal models, oli-
godendrocytes have been demonstrated to be susceptible
to H-I injury [21-24]. This effect seems to be dependent
on both the degree of H-I damage [24] and the timing of
the injury, with late oligodendrocyte progenitors being
more susceptible than early oligodendrocyte precursors or
more mature oligodendrocytes [25]. Our results were con-
sistent with these reports. This window of vulnerability of
the oligodendrocyte coincides with the human popula-
tion at high risk for the development of PVL. This vulner-
ability of the immature oligodendrocytes might explain
the paucity of new, mature oligodendrocytes in our model
on the hypoxic-ischemic side [26].
We found a significant, early increase in BrdU-positive
cells expressing RCA, an endothelial cell marker and
microglial marker, on the side of the brain affected by
hypoxic-ischemic injury. The mechanisms of angiogenesis
in the brain after H-I injury are not well understood, and
there is also little known about angiogenesis in neonatal
animal models. Vascular endothelial growth factor
(VEGF) is endothelial cell specific and has been impli-
cated in hypoxia-mediated angiogenesis [27]. VEGF has
also been demonstrated in microglial cells after cerebral
infarct in adult rats [27]. In the rat brain, angiogenesis is
not completed until about post-natal day 20 [28].
Therefore, it remains a possibility that the increase in cells
co-labeling for BrdU and RCA after H-I injury in our study
partly represents the normal brain maturation process.
However, the increase of these cells on the hypoxic-
ischemic side of the brain would imply that the injury led
to this effect. Further studies will be needed to more accu-
rately identify if there are changes in angiogenesis follow-
ing H-I injury. The majority of these BrdU positive/RCA
positive cells appeared morphologically to be activated
microglia, which are thought to play a role in the damage
to immature oligodendrocytes [20].BMC Neuroscience 2005, 6:15 http://www.biomedcentral.com/1471-2202/6/15
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The present study did not demonstrate an increase in
BrdU-positive cells co-labeling for an astrocyte marker,
GFAP, after H-I injury. Astrocytes have been demonstrated
to express apoptotic enzymes within hours after H-I injury
in neonatal rats [29]. In neonatal piglets, GFAP-positive
cell bodies were reduced by roughly 50% at 48 hours after
H-I injury, but subsets of astrocytes were subsequently
shown to proliferate later after the insult [30]. In adult
rats, the number of astrocytes was shown to remain
unchanged after traumatic brain injury in one study [31],
while in another similar study, there was loss of GFAP
reactivity in the ipsilateral CA3 region of the hippocam-
pus 30 minutes after injury with progressive astrocyte loss
over the next 24 hours [32].
As evidenced by the variability reported in the astrocytic
response to H-I brain injury, the response of this cell in
this environment needs to be better characterized.
Because astrocytes help to maintain the extracellular
milieu needed for neuronal formation and function, it is
possible that their early loss after H-I injury may contrib-
ute to subsequent neuronal degeneration. Future studies
in our neonatal mouse model could be geared towards
better understanding the early response of astrocytes.
Postponing evaluation until three days post-injury in this
model likely resulted in underestimation of the astrocytes'
role in this injury repair process. Chronic hypoxia has
been demonstrated to induce astrocytes into more imma-
ture phenotypes, which do not express normal levels of
GFAP [33]. The ability of acute hypoxia to cause this effect
is not well understood. Therefore, it remains a possibility
that evaluating for immature astrocytes in this model
would have resulted in the visualization of more astro-
cytic cells.
Although the BrdU-positive cells in our study were co-
labeled with stains identifying four separate types of cells,
there were many BrdU-positive cells that were not identi-
fied by these four stains. The co-labeling studies we per-
formed accounted for only about 20% of all the BrdU-
positive cells. The BrdU labeling protocol we used con-
sisted of BrdU injections over the course of the experi-
ment, rather than a one time injection at the time of H-I
injury, which resulted in the staining of more cells than
would be found following a single injection. In this man-
ner, we were able to evaluate how each cell type varied its
number and location at different intervals after the injury.
This provided information about the cellular response to
hypoxic-ischemic brain injury in both the acute and long-
term settings. The role and identity of the non-co-labeled
cells remains unclear. It is probable that these were imma-
ture cell types, not yet expressing the markers for which we
evaluated.
The validity of cells staining for BrdU representing new or
dividing cells versus apoptotic or necrotic cells is also an
issue to be considered. As a result, TUNEL staining was
performed on several hippocampal sections. At P10, three
days after H-I injury, TUNEL staining does reveal apop-
totic and necrotic nuclei. However, by P42, this finding is
virtually non-existent, suggesting that any BrdU-positive
cells are present due to cell proliferation or growth. (See
Figures 4 and 5.) Previous studies have indicated that neu-
rons subjected to H-I injury do, indeed, incorporate BrdU,
but that these injured neurons which undergo apoptosis
have disappeared by 28 days [34].
A possible criticism of the present study is that we did not
count the cells with stereological methods. As a result, our
findings might be due to increased cell density due to sur-
rounding tissue loss as opposed to an increase in the abso-
lute number of new cells present. However, the cell counts
were conducted in non-overlapping sections within a very
short segment of the anterior hippocampus, in which the
sections' thickness remained constant. No gross differ-
ences were observable in brain size in either the coronal or
sagittal planes. Furthermore, hippocampal volume on
both the hypoxia alone and hypoxic-ischemic sides of the
brain did not vary noticeably histologically. Lastly, confo-
cal imaging revealed cell density on each side of the brain
to be roughly equivalent, although exact volumetric meas-
urements can not be made without stereologic
techniques.
Conclusion
Neuronal and other cell regeneration was significantly
increased in the DG on the side of the brain exposed to H-
I injury, as opposed to hypoxic injury alone. This study
addresses the neonatal mouse brain's ability to repair H-I
damage and can serve as a platform to determine if inter-
ventions can be made to augment these inherent repair
mechanisms. The rate of neuronal regeneration found in
our study, while showing a significant increase in the DG,
was not robust. Perhaps the stimulus was insufficient to
result in a great degree of neurogenesis. The degree of
brain injury was not stratified in this study. Neurogenesis
might prove to be proportional to the degree of injury. It
is also possible that this regeneration could increase
further with time, but this is unlikely because new cell
production was decreasing by the final time point after the
injury in our study. Stem cell transplantation or manipu-
lations of factors affecting intrinsic stem cell activity could
be applied to this system in the future.
Methods
Animal procedures
This study was performed in accordance with the guide-
lines provided by the Laboratory Animal Studies
Committee of the Veterans Administration Hospital inBMC Neuroscience 2005, 6:15 http://www.biomedcentral.com/1471-2202/6/15
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Augusta, GA. Under 2% isoflurane anesthesia C57 BL/6
mouse pups underwent permanent ligation of the left
common carotid artery at post-natal day of life seven (P7).
The pups were then placed with the dams for two hours
prior to placement in an 8% oxygen chamber partially
immersed in a water bath at 37° for 75 minutes. This pro-
cedure was described previously in the rat by Levine [12]
and Rice et al [13], and then adapted to the mouse by
Sheldon et al [14]. Within the literature, there is variation
of the neonatal mouse H-I brain injury protocol. Our sev-
enty-five minute hypoxia time was determined by expos-
ing animals to varying intervals of hypoxia. In our
laboratory, seventy-five minutes of hypoxia time resulted
in reliable, reproducible brain injury, with minimal ani-
mal death. Any animal that died during surgery, while in
the hypoxia chamber, or prior to sacrifice time was
excluded. The time at which the animal would be sacri-
ficed was determined prior to surgery. Forty-eight hours
after the H-I injury, the pups were injected intraperito-
neally with BrdU, at a dose of 100 mg/kg. This dose was
administered twice weekly until the pups were sacrificed
at 3, 10, or 35 days after the injury (see Figure 1) with 70
mg/kg of ketamine and 15 mg/kg of xylazine, and tissue
fixation done by transcardiac perfusion with 0.9% saline,
followed by 4% paraformaldehyde in PBS. BrdU injection
was continued twice weekly after injury until the time of
sacrifice in order to elucidate if the types of new cells
found in the hippocampus varied at different time inter-
vals after the injury. This protocol allowed evaluation of
an accumulation of cells, reflecting both the acute and
long-term cellular response to hypoxic and hypoxic-
ischemic injury. Brains were removed and postfixed in 4%
paraformaldehyde for 4 hours, cut into 3–5 mm sections,
and postfixed in 4% paraformaldehyde for an additional
20 hours. Tissue was then dehydrated in an ethanol series,
cleared in xylene, and infiltrated and embedded in Poly-
Fin Embedding and Infiltration Wax (TBS Biomedical Sci-
ences, Durham, NC). Paraffin embedded tissue was
sectioned to 5 µ thickness and mounted on Fisher Super-
frost Plus slides (Fisher Scientific).
Immunohistochemistry and cell counting
Paraffin was removed from slides using xylene, followed
by rehydration in an alcohol dilution series. Slides were
soaked in 0.1% Triton-X 100 in PBS for ten minutes to
increase permeability of fixed tissue, followed by rinsing
in 1X PBS. Antigen retrieval was performed using a micro-
wave method. Slides were incubated for twenty minutes
after slow boiling for ten minutes and then rinsed in PBS
and blocked using 2% normal calf serum for 20 minutes.
Sheep anti-BrdU antibody (Biodesign #M20105S),
diluted 1:200 in PBS, was selected for the visualization of
new cells. Co-labeling runs used mouse anti-NeuN
(Chemicon #MAB377) 1:2000 for the visualization of
neurons, rabbit anti-GFAP (DAKO # Z0334), diluted
1:300 in PBS for the visualization of astrocytes, bioti-
200× magnification of TUNEL staining developed with stable  DAB in the injured hippocampus of a ten day old animal  (P10), showing a small amount of label Figure 4
200× magnification of TUNEL staining developed with stable 
DAB in the injured hippocampus of a ten day old animal 
(P10), showing a small amount of label. Brown coloration 
indicates 3'OH DNA termini (apoptotic or necrotic cells).
200× magnification of TUNEL staining developed with stable  DAB in the injured hippocampus of a 42 day old animal (P42),  showing no labeling of apoptotic or necrotic cells Figure 5
200× magnification of TUNEL staining developed with stable 
DAB in the injured hippocampus of a 42 day old animal (P42), 
showing no labeling of apoptotic or necrotic cells. Brown 
coloration indicates 3'OH DNA termini (apoptotic or 
necrotic cells).BMC Neuroscience 2005, 6:15 http://www.biomedcentral.com/1471-2202/6/15
Page 7 of 9
(page number not for citation purposes)
nylated RCA (Vector #B-1085) diluted 1:300, for the visu-
alization of endothelial cells and microglia cells, and
CNPase (Sigma #C-5922), diluted 1:200, for the visualiza-
tion of oligodendrocytes. All primary antibodies except
NeuN were allowed to incubate at room temperature for
one hour.
Primary NeuN antibody was allowed to incubate for thirty
minutes at room temperature, and washed three times in
a 1X PBS solution. Biotinylated anti-mouse antibody
(Vector Elite ABC Kit #PK-6102), diluted 1:200 in 1.5%
normal horse serum, was applied to each section and
incubated for thirty minutes at room temperature. Slides
were washed in a PBS series before applying Vector Elite
ABC reagent and incubation for thirty minutes at room
temperature. Sections were washed again in PBS and TSA
amplification reagent (NEN #SAT700) with biotinylated
tyramide 1:200 in amplification buffer was applied. Sec-
tions were incubated for eight minutes at room
temperature.
Preliminary staining demonstrated that only NeuN anti-
body required amplification. All other antibodies were
used in an indirect staining method, with a secondary, flu-
orescent antibody. Cy3 anti-Sheep (Jackson # 713-165-
147), diluted 1:400, was used to visualize BrdU in all
cases. FITC anti-rabbit (Jackson # 711-095-152), diluted
1:100, was used to visualize GFAP. Strepavidin FITC (Jack-
son #016-010-084), diluted 1:100, was used to visualize
biotinylated RCA and NeuN. FITC anti-mouse (Jackson
#715-095-151), diluted 1:100, was used to visualize
CNPase.
To reduce background, slides were rinsed in 4 changes of
PBS for 5 minutes each. Secondary antibodies were
applied and incubated for 1 hour. Slides were rinsed in
PBS, and immersed in Hoechst Stain for 8 minutes.
Another rinse series in PBS was applied before coverslip-
ping, using Vectashield Mounting medium. (Vector #H-
1000)
Cells were counted in 4–6 animals at each time interval.
For each animal, the cells were counted from the injury
area in the anterior hippocampus (equivalent adult
mouse interaural coordinates 2.10 to 1.98 mm) [15] in
CA1, CA3, and DG. (In Figure 2, the circles show the spe-
cific fields, CA1, CA3, and the DG, counted under one 40×
magnification field in each section of brain. Correspond-
ing areas of hippocampus were estimated in each section
of brain when choosing the 40X field.) At least three brain
sections from each animal for each stain type were
counted. Therefore, each brain had three CA1, three CA3,
and three DG 40X fields stained and counted with BrdU,
one of the four co-labeling cell markers, and Hoescht
stain. In each case, the same observer performed the cell
counting in all brain sections. The counter could not be
blinded due to the loss of normal architecture on the side
of the brain consistent with H-I injury. A separate observer
did count numerous sections in order to ensure consist-
Schematic diagram showing BrdU injection schedule Figure 1
Schematic diagram showing BrdU injection scheduleBMC Neuroscience 2005, 6:15 http://www.biomedcentral.com/1471-2202/6/15
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ency and accuracy. Each 40X field counted by separate
individuals was found to have consistent data. Counting
was completed by counting the total number of cells
labeled for BrdU only and for BrdU co-labeled with one of
the four the cell markers found in one field under 40×
magnification in each of the three regions in the hippoc-
ampus, on both the hypoxia alone and hypoxic-ischemic
side of the brain. Due to the large size of the hippocampus
and the H-I injury, analysis was confined to one level of
the brain cut through the middle of the injury. Any BrdU-
only cells with abnormal morphology and any co-labeled
cells were confirmed by corresponding Hoescht staining.
Confocal imaging
To confirm dual labeling, confocal imaging was per-
formed in selected cells with a Zeiss 510 laser scanning
confocal microscope with the use of Zeiss software. The
objective used was Zeiss63x C-Apochromat 1.2 NA. To
excite the FITC fluorochrome (green), a 488-nm laser line
generated by an argon laser was used, and for the Cy3
fluorochrome (red), a 543-nm laser line from a HeNe
laser was used. Filter sets used were a bandpass 500- to
600- filter ("green" channel) and a long-pass 585- to 650-
nm filter ("red" channel). We identified cells that were
labeled for BrdU and the neuronal marker NeuN. These
cells were then examined by confocal microscopy, and 1-
µm step Z series were obtained. (See Figure 3.)
TUNEL staining
Staining for the presence of apoptotic cells was completed
using the ApopTag Peroxidase Kit (Chemicon #S7100),
according to manufacturer recommendations. Therefore,
after rehydration, the tissue was treated with Proteinase K
(20 µg/mL) and incubated for 15 minutes. Endogenous
peroxidases were quenched with hydrogen peroxide. Sec-
tions were then treated with equilibration buffer and TdT
enzyme treatment. Next, the sections were stained with
anti-dioxigenin peroxidase conjugate for 30 minutes, and
the slides were developed with stable DAB.
Statistical analyses
Nested, repeated measures analysis of variance was used
to examine differences in number of cells between times
of sacrifice (10, 17, or 42 days), side of brain (hypoxia
alone or hypoxic-ischemic injury), region of the hippoc-
ampus (CA1, CA3, DG) and antibody type (CNPase,
GFAP, NeuN, and RCA). A second analysis was performed
using only BrdU-positive cells. Post hoc analyses were
Three dimensional reconstructed confocal microscopy demonstrating colabeling BrdU positive and NeuN positive cell in gran- ule cell layer of HI injured hippocampus (P42) Figure 3
Three dimensional reconstructed confocal microscopy demonstrating colabeling BrdU positive and NeuN positive cell in gran-
ule cell layer of HI injured hippocampus (P42). Orthogonal view. The neurons are labeled with NeuN (green), and the BrdU 
positive cells are shown in red. The square is a the Z slice, the superior rectangle is the X slice, and the right rectangle of the Y 
slice. A and B show two different cells, both co-labeled with BrdU and NeuN.BMC Neuroscience 2005, 6:15 http://www.biomedcentral.com/1471-2202/6/15
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performed using the adjusted least square means and
applying a Bonferroni correction to the overall alpha
level. Statistical significance was assessed using an alpha
level of 0.05. All analyses were performed using SAS 8.2.
Abbreviations
hypoxic-ischemic – H-I, bromodeoxyuridine – BrdU, sub-
ventricular zone – SVZ, subgranular zone – SGZ, dentate
gyrus – DG, glial fibrillary acidic protein – GFAP, 2'3'-
cyclic nucleotide 3'-phosphodiesterase -CNPase, Ricinus
communis agglutinin I –s RCA, neuronal nuclear marker –
NeuN
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